Mira Pharmaceuticals, Inc. (MIRA) — 10-K/A Filings

All 10-K/A filings from Mira Pharmaceuticals, Inc.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.

10-K/A Filings (2)

  • Mira Pharmaceuticals Files 2024 10-K Amendment — Apr 17, 2025 Risk: low
    Mira Pharmaceuticals, Inc. filed an amendment (No. 2) to its 2024 annual report on April 17, 2025. The company, formerly known as Mira1a Therapeutics, Inc., is
  • Mira Pharmaceuticals Files 10-K/A Amendment — Apr 15, 2025 Risk: medium
    Mira Pharmaceuticals, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Mira1a T

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.